The Chemours Co/ US1638511089 /
14/11/2024 21:59:53 | Chg. +0.16 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
19.32USD | +0.81% | 56,816 Turnover: 1.09 mill. |
-Bid Size: - | -Ask Size: - | 2.89 bill.USD | 5.18% | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | -1.60 USD | -143.01% |
EPS Diluted: | -1.60 USD | - |
Revenues per Share: | 40.50 USD | -11.57% |
Book Value per Share: | 4.97 USD | -33.45% |
Cash Flow per Share: | 3.74 USD | -26.49% |
Dividend per Share: | 1.00 USD | 0.00% |
Total | in mill. | |
Revenues: | 6,027.00 USD | -11.29% |
Net Income: | -238.00 USD | -141.18% |
Operating Cash Flow: | 556.00 USD | - |
Cash and Cash Equivalents: | 1,203.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | 0.48 | 0.78 |
P/BV ratio: | 3.89 | 6.35 |
P/CF Ratio: | 5.17 | 8.44 |
PEG: | 0.08 | - |
Earnings Yield: | -8.28% | -5.07% |
Dividend Yield: | 5.18% | 3.17% |
Market Capitalization | ||
Market Capitalization: | 2.89 bill. USD | 4.69 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 149.41 mill. |
Profitability
Gross Profit Margin: | 21.67% |
EBIT Margin: | 0.00% |
Net Profit Margin: | -3.95% |
Return on Equity: | -32.21% |
Return on Assets: | -2.88% |
Financial Strength
Liquidity I / Cash Ratio: | 0.48% |
Liquidity II / Quick Ratio: | 0.73% |
Liquidity III / Current Ratio: | 1.54% |
Debt / Equity Ratio: | 5.46% |
Dynam. Debt / Equity Ratio: | 1,351.08% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |